B02BDN1 • treated fresh frozen human plasma • Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Treated fresh frozen human plasma is a biological product used in the treatment of coagulation disorders, such as coagulation factor deficiencies or massive bleeding. It contains coagulation factors, proteins, and other essential components for hemostasis.
The product is administered intravenously, usually in emergency situations or during surgical procedures, as directed by the doctor. It is important to use it under controlled conditions to prevent adverse reactions.
Side effects may include allergic reactions, fever, infections, or, in rare cases, hemolytic reactions.
Patients should inform their doctor about any known allergies or other conditions to ensure the safe use of treated fresh frozen human plasma.
Substance: treated fresh frozen human plasma
Date of last drug list: 01-07-2013
Commercial code: W13465002
Concentration: 45-70mg / ml
Pharmaceutical form: solution for infusion
Quantity: 10
Product type: generic
Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.